Trial intelligence / Profile preview

Pilot mannitol challenge study in adults with asthma receiving fixed-dose combination inhalers

2011-000939-86Phase 4Completed

Sponsor
Mundipharma
Start
Apr 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of budesonide, salmeterol + fluticasone, beclometasone dipropionate + formoterol and Bronchitol in asthma, sponsored by Mundipharma. Primary endpoint: Mannitol challenge test plus reversibility test response. Started Apr 2011; status: completed.

02

Drugs

budesonidesalmeterol + fluticasonebeclometasone dipropionate + formoterolBronchitol
03

Conditions

asthma

Beyond the preview

Go deeper on 2011-000939-86.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000939-86.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call